MedTrace Logo

The Effect of Coleus Forskohlii Extract on the Risk Factors of Metabolic Syndrome

NCT02143349 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2014-05-21

No results posted yet for this study

Summary

Coleus forskohlii extract contains the bioactive compound, forskolin. Preliminary studies have shown that forskolin can increase fat metabolism thus reduce fat accumulation in both animals and humans. It has been suggested that forskolin may also suppress appetite thus reduce energy intake and results in weight loss. This study will evaluate the appetite suppressant properties of Coleus forskohlii extract. In addition the effect on central obesity and risk factors of metabolic syndrome will also be investigated.

Conditions

Interventions

DIETARY_SUPPLEMENT

Coleus forskohlii extract

Ingestion of 250 mg Coleus forskohlii extract capsule twice a day for 12 weeks

OTHER

Placebo

Ingestion of 250 mg placebo capsule twice a day for 12 weeks

Sponsors & Collaborators

  • College of Health and Biomedicine, Victoria University

    collaborator UNKNOWN

  • Olive Lifesciences Pvt Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02143349 on ClinicalTrials.gov